Consonance Capital Partners, LP

Consonance Capital Partners advises and manages private investment funds and co‑investment vehicles that invest exclusively in healthcare businesses. The firm provides discretionary private equity management across flagship, continuation, parallel and feeder vehicles, pursuing growth equity, leveraged buyout and build‑up transactions.

The firm employs a proactive, targeted sourcing process driven by macro “investable themes” across healthcare subsectors and active outreach to prioritized targets. Investment teams work with an Operating Council of healthcare operating executives and a Senior Advisory Board to support diligence, strategy and portfolio oversight, and the firm allocates co‑investment opportunities on a case‑by‑case basis.

Consonance’s brochure discloses a number of features that distinguish it from many peers: it uses endorsements and highlights OC/SAB members’ reputations in marketing materials and on its website, employs alternative data and AI tools in diligence in limited circumstances, and discloses that OC/SAB members may be paid by portfolio companies for consulting or board services. With approximately $2.76 billion under management, the firm’s concentrated healthcare focus, structured operating council, and explicit use of endorsements and newer data/AI methods set it apart from more generalist investment managers.